These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 7293820)

  • 1. Sulfadimidine acetylation in Norwegians. Comparison of sulfadimidine metabolism in Lapps, North Norwegians and South Norwegians.
    Olsen H; Mørland J
    Acta Med Scand; 1981; 210(1-2):119-24. PubMed ID: 7293820
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sulfadimidine and isoniazid loading in man and laboratory rats. Pharmacokinetic and pharmacogenetic results on drug acetylation.
    Dubbels R; Kattner E; Sell-Maurer D; Schloot W
    Arzneimittelforschung; 1980; 30(9):1574-9. PubMed ID: 7193028
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Biotransformation of phenazone and sulfadimidine as markers of liver metabolism of drug and xenobiotic oxidation and acetylation in women with breast cancer].
    Orzechowska-Juzwenko K; Wiela-Hojeńska A; Milejski P; Cieślińska A; Hudziec P; Adamska M
    Przegl Lek; 1997; 54(2):103-6. PubMed ID: 9198818
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biostatics of the tibial shaft.
    Ljunggren AE
    Acta Morphol Neerl Scand; 1975 Nov; 13(3):145-70. PubMed ID: 1211223
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Undernourished adults and acetylation phenotype.
    Arunkumar Shastri R
    Int J Clin Pharmacol Ther Toxicol; 1982 Apr; 20(4):194-6. PubMed ID: 7076349
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics, metabolism, and renal excretion of sulfadimidine and its N4-acetyl and hydroxy metabolites in humans.
    Vree TB; Hekster YA; Nouws JF; Baakman M
    Ther Drug Monit; 1986; 8(4):434-9. PubMed ID: 3824429
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bioavailability factors of isoniazid in fast and slow acetylators, healthy volunteers.
    Augustynowicz-Kopeć E; Zwolska Z
    Acta Pol Pharm; 2002; 59(6):452-7. PubMed ID: 12669770
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The tuberositas tibiae and extension in the knee joint.
    Ljunggren AE
    Acta Morphol Neerl Scand; 1976 Sep; 14(3):215-39. PubMed ID: 1007969
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acetylator phenotypes: allele frequency in northwestern Argentina and review of acetylator distribution in the Americas.
    Dipierri JE; Alfaro E; Bejarano IF; Etchart AA
    Hum Biol; 1998 Oct; 70(5):959-64. PubMed ID: 9780522
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Variations in the relationship between the diaphysis and the epiphyses of the tibia.
    Ljunggren AE
    Acta Morphol Neerl Scand; 1976 Jun; 14(2):101-37. PubMed ID: 1015362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acetylation phenotype and skin complexion.
    Rampen FH; van der Meeren HL; Stolk LM
    Acta Derm Venereol; 1986; 66(4):334-6. PubMed ID: 2430405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ecogenetic studies of drug acetylation in man and rats.
    Dubbels R; Khoory R; Schloot W
    Acta Anthropogenet; 1981; 5(2):111-8. PubMed ID: 7271997
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison between serum isonicotinic acid hydrazide (INH) levels and urinary sulfadimidine (sulfamethazine) acetylation as predictors of INH acetylator status.
    Seth V; Seth SD; Beotra A; Singh U
    Dev Pharmacol Ther; 1988; 11(1):32-6. PubMed ID: 3383719
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activity of N-acetyltransferase in patients with malignant lymphomas.
    Chekharina YeA ; Bulovskaya LN; Pavlova MV; Krupkin RG
    Neoplasma; 1978; 25(4):471-5. PubMed ID: 692806
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison between serum and urinary sulphadimidine acetylation as predictors of isoniazid acetylator status in patients with pulmonary tuberculosis.
    Singh SP; Pande JN; Khilnani GC; Kailash S
    Indian J Chest Dis Allied Sci; 1996; 38(1):5-11. PubMed ID: 16892742
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dipyrone metabolism in liver disease.
    Zylber-Katz E; Caraco Y; Granit L; Levy M
    Clin Pharmacol Ther; 1995 Aug; 58(2):198-209. PubMed ID: 7648770
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Coronary heart diseases among Lapps and Norwegians in Finnmark].
    Utsi E; Bønaa KH
    Tidsskr Nor Laegeforen; 1998 Mar; 118(9):1358-62. PubMed ID: 9599498
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetically determined sparteine oxidation and sulfadimidine acetylation polymorphism in patients with non-occupational urinary bladder cancer.
    Orzechowska-Juzwenko K; Niewiński P; Pawlik J; Milejski P; Dembowski J; Swiebodzki L; Lorenz J
    Mater Med Pol; 1994; 26(4):145-8. PubMed ID: 7666680
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Acetylation phenotype in patients with periodic disease].
    Podymov VK; Vinogradova OM; Kovaleva VL; Kochubeĭ LN; Galstian SM
    Ter Arkh; 1988; 60(6):95-8. PubMed ID: 3206381
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acetylator phenotyping in patients with malignant lymphomas, using caffeine as the metabolic probe.
    William BM; Abdel-tawab AM; Hassan EA; Mohamed OF
    Pol J Pharmacol; 2004; 56(4):445-9. PubMed ID: 15520499
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.